Stock Track | Quidel Soars 9.66% Pre-Market as Q4 Results Beat Expectations and Cost Cuts Fuel Growth Outlook

Stock Track02-13

Quidel Corporation (QDEL) saw its stock surge 9.66% in the pre-market trading session on Thursday, driven by the company's better-than-expected Q4 2024 financial results and optimistic 2025 guidance, fueled by ongoing cost reduction initiatives.

Despite a 4% year-over-year decline in Q4 2024 revenue to $708 million, primarily due to lower COVID-19 and flu testing demand, Quidel's adjusted EBITDA margin of 21% and adjusted diluted EPS of $0.63 exceeded analysts' expectations. The company's strong performance can be attributed to its focus on non-respiratory revenue, which accounted for $2.3 billion of its $2.8 billion full-year 2024 revenue.

Looking ahead, Quidel provided an encouraging outlook for 2025, with revenue guidance ranging from $2.6 billion to $2.81 billion and adjusted EBITDA guidance of $575 million to $615 million, representing a 22% margin. This positive guidance is underpinned by the company's ongoing cost reduction initiatives, which include procurement savings and other measures aimed at driving margin expansion by 250 basis points in 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1123432482?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2025-02-13 22:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1123432482","market":"hk","top_or_hot":-1,"title":"Stock Track | Quidel Soars 9.66% Pre-Market as Q4 Results Beat Expectations and Cost Cuts Fuel Growth Outlook","media":"Stock Track","content":"<p>Quidel Corporation (QDEL) saw its stock surge 9.66% in the pre-market trading session on Thursday, driven by the company's better-than-expected Q4 2024 financial results and optimistic 2025 guidance, fueled by ongoing cost reduction initiatives.</p>\n\n<p>Despite a 4% year-over-year decline in Q4 2024 revenue to $708 million, primarily due to lower COVID-19 and flu testing demand, Quidel's adjusted EBITDA margin of 21% and adjusted diluted EPS of $0.63 exceeded analysts' expectations. The company's strong performance can be attributed to its focus on non-respiratory revenue, which accounted for $2.3 billion of its $2.8 billion full-year 2024 revenue.</p>\n\n<p>Looking ahead, Quidel provided an encouraging outlook for 2025, with revenue guidance ranging from $2.6 billion to $2.81 billion and adjusted EBITDA guidance of $575 million to $615 million, representing a 22% margin. This positive guidance is underpinned by the company's ongoing cost reduction initiatives, which include procurement savings and other measures aimed at driving margin expansion by 250 basis points in 2025.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Quidel Soars 9.66% Pre-Market as Q4 Results Beat Expectations and Cost Cuts Fuel Growth Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Quidel Soars 9.66% Pre-Market as Q4 Results Beat Expectations and Cost Cuts Fuel Growth Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-13 22:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Quidel Corporation (QDEL) saw its stock surge 9.66% in the pre-market trading session on Thursday, driven by the company's better-than-expected Q4 2024 financial results and optimistic 2025 guidance, fueled by ongoing cost reduction initiatives.</p>\n\n<p>Despite a 4% year-over-year decline in Q4 2024 revenue to $708 million, primarily due to lower COVID-19 and flu testing demand, Quidel's adjusted EBITDA margin of 21% and adjusted diluted EPS of $0.63 exceeded analysts' expectations. The company's strong performance can be attributed to its focus on non-respiratory revenue, which accounted for $2.3 billion of its $2.8 billion full-year 2024 revenue.</p>\n\n<p>Looking ahead, Quidel provided an encouraging outlook for 2025, with revenue guidance ranging from $2.6 billion to $2.81 billion and adjusted EBITDA guidance of $575 million to $615 million, representing a 22% margin. This positive guidance is underpinned by the company's ongoing cost reduction initiatives, which include procurement savings and other measures aimed at driving margin expansion by 250 basis points in 2025.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"QDEL","symbol_name":"窥得儿医药","start_time":0,"source_url":"","article_id":"1123432482","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1123432482","pubTimestamp":1739457623,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Quidel Corporation  saw its stock surge 9.66% in the pre-market trading session on Thursday, driven by the company's better-than-expected Q4 2024 financial results and optimistic 2025 guidance, fueled by ongoing cost reduction initiatives.Despite a 4% year-over-year decline in Q4 2024 revenue to $708 million, primarily due to lower COVID-19 and flu testing demand, Quidel's adjusted EBITDA margin of 21% and adjusted diluted EPS of $0.63 exceeded analysts' expectations. The company's strong perfor","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"QDEL":"窥得儿医药"},"translate_title":"由于第四季度业绩超出预期且成本削减提振增长前景，Quidel股价盘前飙升9.66%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"QDEL":1},"content_text":"Quidel Corporation (QDEL) saw its stock surge 9.66% in the pre-market trading session on Thursday, driven by the company's better-than-expected Q4 2024 financial results and optimistic 2025 guidance, fueled by ongoing cost reduction initiatives.\nDespite a 4% year-over-year decline in Q4 2024 revenue to $708 million, primarily due to lower COVID-19 and flu testing demand, Quidel's adjusted EBITDA margin of 21% and adjusted diluted EPS of $0.63 exceeded analysts' expectations. The company's strong performance can be attributed to its focus on non-respiratory revenue, which accounted for $2.3 billion of its $2.8 billion full-year 2024 revenue.\nLooking ahead, Quidel provided an encouraging outlook for 2025, with revenue guidance ranging from $2.6 billion to $2.81 billion and adjusted EBITDA guidance of $575 million to $615 million, representing a 22% margin. This positive guidance is underpinned by the company's ongoing cost reduction initiatives, which include procurement savings and other measures aimed at driving margin expansion by 250 basis points in 2025.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1123432482"}